Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
Public ClinicalTrials.gov record NCT00006054. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00006054
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Fairview University Medical Center
- Other
- Enrollment
- Not listed
Conditions and interventions
Conditions
- Chediak-Higashi Syndrome
- Chronic Granulomatous Disease
- Common Variable Immunodeficiency
- Familial Erythrophagocytic Lymphohistiocytosis
- Graft Versus Host Disease
- Hemophagocytic Lymphohistiocytosis
- Immunologic Deficiency Syndromes
- Leukocyte Adhesion Deficiency Syndrome
- Severe Combined Immunodeficiency
- Virus-Associated Hemophagocytic Syndrome
- Wiskott-Aldrich Syndrome
- X-Linked Lymphoproliferative Syndrome
- X-linked Agammaglobulinemia
- X-linked Hyper IgM Syndrome
Interventions
- Allogeneic Bone Marrow Transplantation Procedure
- anti-thymocyte globulin Drug
- busulfan Drug
- cyclophosphamide Drug
- cyclosporine Drug
- etoposide Drug
- methotrexate Drug
- methylprednisolone Drug
- prednisone Drug
Procedure · Drug
Eligibility (public fields only)
- Age range
- Up to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2000
- Primary completion
- Nov 30, 2002
- Completion
- Nov 30, 2002
- Last update posted
- Oct 14, 2009
2000 – 2002
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fairview University Medical Center | Minneapolis | Minnesota | 55455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00006054, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2009 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00006054 live on ClinicalTrials.gov.